Pfizer and BioNTech's COVID-19 vaccine demonstrates over 90% efficacy as hope builds for an early end to the pandem… https://t.co/7oajgLXB0B
IHS at ISPOR Montreal, 2-4 June 2014. Visit us at Table 136!
The IHS Life Sciences team is pleased to announce that we will again have a strong presence at the ISPOR 19th Annual International Meeting in Montreal, Canada.
Come by Table 136 to meet members of our team and learn about our expanded offerings and latest research.
We are hosting an "Ice Cream Social" on Monday, 2 June starting at 6:30 pm. We hope you are able to stop by and meet with us to see how we can help you address all of your business needs. You can follow our analysis as they experience the event on twitter @IHS4LifeScience and here on the blog as well.
- Pfizer and BioNTech's COVID-19 vaccine
- Mixed news on COVID19 vaccines: COVID-19 R&D tracker
- Innovation in Japan’s regenerative sector
- US drug prices could be drastically impacted by Most Favored Nation executive order
- Global healthcare spend to remain stable
- The pandemic pricing dilemma: A COVID-19 vaccine at-cost or for profit?
- US school re-opening decisions in a pandemic environment are complex – data can help
- Trump resurrects International Reference Pricing (IRP) proposal on pharmaceuticals with executive order
RELATED INDUSTRIES & TOPICS
Register from the latest on the progression of the pandemic and the future that lies ahead of us from our Vice Pres… https://t.co/GiqhM1V318
We are expecting major clinical readouts from several key COVID-19 vaccine and therapeutics candidates- our weekly… https://t.co/aIcNOmccrx